MiR-0766 induces p53 accumulation and G2/M arrest by directly targeting MDM4

被引:32
|
作者
Wang, Qingqing [1 ]
Selth, Luke A. [2 ,3 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Sch Med, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
MicroRNA; MDM4; p53; cancer; cell cycle; TUMOR-SUPPRESSOR P53; MUTANT P53; MICRORNA EXPRESSION; NEGATIVE REGULATION; POSITIVE FEEDBACK; GENE-EXPRESSION; MIR-34A; PROLIFERATION; ONCOPROTEIN; TRANSITION;
D O I
10.18632/oncotarget.15530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53, a transcription factor that participates in multiple cellular functions, is considered the most important tumor suppressor. Previous evidence suggests that post-transcriptional deregulation of p53 by microRNAs contributes to tumorigenesis, tumor progression and therapeutic resistance. In the present study, we found that the microRNA miR-766 was aberrantly expressed in breast cancer, and that overexpression of miR-766 caused accumulation of wild-type p53 protein in multiple cancer cell lines. Supporting its role in the p53 signalling pathway, miR-766 decreased cell proliferation and colony formation in several cancer cell lines, and cell cycle analyses revealed that miR-766 causes G2 arrest. At a mechanistic level, we demonstrate that miR-766 enhances p53 signalling by directly targeting MDM4, an oncogene and negative regulator of p53. Analysis of clinical genomic data from multiple cancer types supports the relevance of miR-766 in p53 signalling. Collectively, our study demonstrates that miR-766 can function as a novel tumor suppressor by enhancing p53 signalling.
引用
收藏
页码:29914 / 29924
页数:11
相关论文
共 50 条
  • [11] Selective and dual action p53/mdm2/mdm4 antagonists
    Wang, Kan
    Doemling, Alexander
    CANCER RESEARCH, 2009, 69
  • [12] Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4
    Chandler, Dawn S.
    Singh, Ravi K.
    Caldwell, Lisa C.
    Bitler, Jaquelyn L.
    Lozan, Guillermina
    CANCER RESEARCH, 2006, 66 (19) : 9502 - 9508
  • [13] Mdm2 and Mdm4 loss regulates distinct p53 activities
    Barboza, Juan A.
    Iwakuma, Tomoo
    Terzian, Tamara
    El-Naggar, Adel K.
    Lozano, Guillermina
    MOLECULAR CANCER RESEARCH, 2008, 6 (06) : 947 - 954
  • [14] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [15] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [16] Gα12/13 basally regulates p53 through Mdm4 expression
    Kim, Mi-Sung
    Lee, Sang Min
    Kim, Won Dong
    Ki, Sung Hwan
    Moon, Aree
    Lee, Chang Ho
    Kim, Sang Geon
    MOLECULAR CANCER RESEARCH, 2007, 5 (05) : 473 - 484
  • [17] Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4
    Grier, JD
    Xiong, SB
    Elizondo-Fraire, AC
    Parant, JM
    Lozano, G
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) : 192 - 198
  • [18] Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review
    Teveroni, Emanuela
    Luca, Rossella
    Pellegrino, Marsha
    Ciolli, Germana
    Pontecorvi, Alfredo
    Moretti, Fabiola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (12) : 1417 - 1429
  • [19] Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
    Marine, J-C
    Francoz, S.
    Maetens, M.
    Wahl, G.
    Toledo, F.
    Lozano, G.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (06): : 927 - 934
  • [20] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000